| Dr Kathryn A Hopfensperger, MD | |
|
510 W 29th St, Cheyenne, WY 82001-2760 | |
| (307) 637-3953 | |
| Not Available |
| Full Name | Dr Kathryn A Hopfensperger |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 36 Years |
| Location | 510 W 29th St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467530659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 6597A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheyenne Regional Medical Center | Cheyenne, WY | Hospital |
| Sheridan Memorial Hospital | Sheridan, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Volunteers Of America Northern Rockies | 1355733015 | 16 |
News Archive
Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.
The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects.
Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.
› Verified 2 days ago
| Entity Name | Peak Wellness Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306845920 PECOS PAC ID: 7911993662 Enrollment ID: O20040420001693 |
News Archive
Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.
The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects.
Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.
› Verified 2 days ago
| Entity Name | Tms Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255732632 PECOS PAC ID: 6002113057 Enrollment ID: O20190918001755 |
News Archive
Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.
The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects.
Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.
› Verified 2 days ago
| Entity Name | Volunteers Of America Northern Rockies |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689249682 PECOS PAC ID: 1355733015 Enrollment ID: O20220110002012 |
News Archive
Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.
The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects.
Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn A Hopfensperger, MD 510 W 29th St, Cheyenne, WY 82001-2760 Ph: () - | Dr Kathryn A Hopfensperger, MD 510 W 29th St, Cheyenne, WY 82001-2760 Ph: (307) 637-3953 |
News Archive
Today, the European Congress on Osteoporosis and Osteoarthritis opened in Valencia, Spain with some 4000 international participants. The Congress is the major annual European meeting in the bone field and attracts clinicians, specialists and bone experts from around the world. ECCEO11-IOF continues until March 26th at Valencia's Palacio de Congresos.
The FDA has granted Orphan Drug Designation of Diamyd Medical´s lead drug candidate Diamyd®. Orphan drugs qualify for seven years of market exclusivity from the date of US marketing approval, tax credits for clinical research and a waiver for FDA user fees.
A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects.
Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.
› Verified 2 days ago
Dr. Julie Anne Toshcoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 | |
Jie Chen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 18th St, Cheyenne, WY 82001 Phone: 307-633-7370 Fax: 307-633-7202 | |
Celina Frances Tolge, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2301 House Ave, Suite 203, Cheyenne, WY 82001 Phone: 307-432-0335 Fax: 307-432-0341 | |
Tracie Caller, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2301 House Ave Ste 201, Cheyenne, WY 82001 Phone: 307-638-7757 Fax: 307-638-8399 | |
Terri Orcutt, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 | |
Benjamin Tankever Johnson, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2600 E 18th St, Cheyenne, WY 82001 Phone: 307-633-7370 Fax: 307-637-7202 | |
Reed Clifton Shafer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5050 Powderhouse Rd, Cheyenne, WY 82009 Phone: 307-634-1311 Fax: 307-634-1271 |